Novel Bacillus strains from the human gut exert anticancer effects on a broad range of malignancy types

Man-Fei Zhao1, Gong-Da Liang1, Yu-Jie Zhou2,3

  • 1Department of Epidemiology, Public Health School, Harbin Medical University, Harbin, Heilongjiang Province, China.

Insights

Researchers identified four novel Bacillus strains from fecal samples that inhibit the proliferation of ovarian and colorectal cancer cells. These gut bacteria show potential as promising new anticancer agents by inducing apoptosis.

Area of Science:

  • Microbiology
  • Oncology
  • Gut Microbiome Research

Background:

  • Cancer remains a leading global cause of mortality, necessitating novel therapeutic strategies.
  • The gut microbiota's role in cancer treatment is increasingly recognized, yet few microbes with therapeutic potential have been identified.

Purpose of the Study:

  • To isolate and characterize novel gut bacteria with potential anticancer properties.
  • To evaluate the efficacy of isolated bacterial strains against ovarian and colorectal cancer cells.

Main Methods:

  • Isolation of bacterial strains (BY38, BY40, BY43, BY45) from fecal specimens.
  • In vitro assays to assess the impact of bacterial products on cancer cell proliferation.
  • Phylogenetic analysis to identify bacterial species.
  • Flow cytometry to investigate mechanisms of cell death induction (apoptosis).

Main Results:

  • Bacterial strains BY38, BY40, BY43, and BY45 demonstrated significant, dose-dependent inhibition of ovarian and colorectal cancer cell proliferation.
  • Phylogenetic analysis confirmed the strains belong to the genus Bacillus.
  • Flow cytometry suggested that the anticancer effects are mediated through the induction of apoptosis.

Conclusions:

  • The isolated Bacillus strains represent promising candidates for novel anticancer agents.
  • Further research into these gut bacteria could lead to new therapeutic approaches for cancer treatment.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
861
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.5K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.4K